Enteral feeding refers to intake of food via the gastrointestinal (GI) tract. The GI tract is composed of the mouth, esophagus, stomach, and intestines. Enteral feeding also refers to the nutrition taken through the mouth or through a tube that goes directly to the stomach or small intestine. In the medical setting, the term enteral feeding is mostly used to mean tube feeding. According to the American College of Gastroenterology, there are six main types of feeding tubes which include Nasogastric tube (NGT), Orogastric tube (OGT), Nasoenteric tube, Oroenteric tube, Gastrostomy tube, and Jejunostomy tube. These tubes may have further subtypes depending on exactly where they end in the stomach or intestines.
The global enteral feeding devices market is estimated to be valued at US$ 3,260.6 million in 2020 and is expected to exhibit a CAGR of 5.8% over the forecast period (2020-2027).
Figure 1. Global Enteral Feeding Devices Market Share (%) in Terms of Value, By Region, 2020
Increasing geriatric population and prevalence of chronic disease is expected to drive the market growth over the forecast period
Major factors assisting in the market growth during the forecast period are the increasing geriatric population and prevalence of chronic disease.
According to a 2017 report by the United Nations, the global population is aging at a faster rate in developed regions. For instance, as per the report, 33.4% of the population in Japan is in the age group of 60 years or above, which is expected to rise 42.4% by 2050.
Enteral feeding devices are recommended by the dietitian to meet nutritional requirements for patients with diabetes. Special high-protein diabetes-specific formulas are administered through these tubes, which reduce the insulin need for the patients. This leads to improved glycemic control, which is important for the longevity of the patient.
Furthermore, the increasing prevalence of diabetes is also expected to aid growth of the market.
According to a study title ‘Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition’, published in the Diabetes Research and Clinical Practice journal in September 2019, 463 million people are expected to suffer from diabetes in 2019 worldwide and the number is expected to reach 578 million by 2030 and 700 million by 2045.
Figure 2. Global Enteral Feeding Devices Market Share (%), by Product Type, 2020
Increasing product launches and approvals is expected to drive the market growth over the forecast period
The enteral feeding devices market is expected to witness significant growth during the forecast period owing to the increasing number of product approvals and launches by key players in the market.
In May 2019, NeoMed, Inc., a medical devices company launched NeoConnect at Home, a reusable portfolio of ENFit syringes that do not require a physician’s prescription.
In March 2019, Medtronic Plc., a medical devices company launched the Medtronic MedTech Innovation Accelerator in Pujiang International Science and Technology City at Minhang District, Shanghai.
|Base Year:||2019||Market Size in 2020:||US$ 3,260.6 Mn|
|Historical Data for:||2016 to 2019||Forecast Period:||2020 to 2027|
|Forecast Period 2020 to 2027 CAGR:||5.8%||2027 Value Projection:||US$ 4,853.8 Mn|
Cook Group, Abbott Laboratories, Cardinal Health, Inc., Boston Scientific Corporation, CONMED Corporation, Amsino International Inc., Applied Medical Technology, Inc., Becton, Dickinson and Company, B. Braun Melsungen AG, Fresenius SE & Co. KGaA, Moog, Inc., Vygon S.A, Dynarex Corporation, and Medela AG.
|Restraints & Challenges:||
Global Enteral Feeding Devices Market – Impact of Coronavirus (Covid-19) Pandemic
Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 100 countries across the globe and the World Health Organization has declared it a public health emergency. According to the World Health Organization’s report, the manifestation of coronavirus disease (COVID-19) has resulted in more than 17.3 million infected individuals worldwide as of 26th April, 2021.
COVID-19 can affect the economy in three main ways; by directly affecting production and demand, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to nationwide lockdowns, several countries such as China, India, Saudi Arabia, UAE, Egypt, and others are facing problems with regards to transportation of drugs from one place to another.
Furthermore, players operating in the global enteral feeding devices market are facing major challenges on various fronts due to the COVID-19 pandemic. The major challenges include supply of raw materials required for manufacturing enteral feeding devices due to irregularities in transportation facility. Moreover, distributors of products are experiencing irregular demand for products from the retailers due to increasing number of patients suffering from COVID-19 and other life threatening disorders.
Global Enteral Feeding Devices Market Restraint
Complications associated with enteral feeding are expected to hinder growth of the global enteral feeding devices market. These complications include nausea, vomiting, diarrhea, malabsorption, pulmonary aspiration, tube malposition, and tube clogging.
Moreover, bacterial contamination of the enteral feed is also expected to limit growth of the market.
Major players operating in the global enteral feeding devices market include Cook Group, Abbott Laboratories, Cardinal Health, Inc., Boston Scientific Corporation, CONMED Corporation, Amsino International Inc., Applied Medical Technology, Inc., Becton, Dickinson and Company, B. Braun Melsungen AG, Fresenius SE & Co. KGaA, Moog, Inc., Vygon S.A, Dynarex Corporation, and Medela AG.
Enteral feeding devices deliver nutrients through a tube to patients who are unable to swallow their food. Enteral nutrition is generally administered to pediatric and geriatric patients using nasogastric tube and gastrostomy or Percutaneous Endoscopic Gastrostomy (PEG) tube. Enteral nutrition is often used for pediatric and geriatric patients. Gastroenteric tube feeding is used in the management of patients with poor voluntary intake, chronic neurological or mechanical dysphagia or gut dysfunction. Increasing prevalence of cancer and other chronic diseases is also expected to aid in growth of the market. Moreover, increasing expenditure on gastrointestinal disorders along with rapidly increasing geriatric population is anticipated to assist the growth of the market during the forecast period.
Key players operating in the market are focusing on development and launch of novel enteral feeding devices which is anticipated to drive the market growth over the forecast period. For instance, in March 2017, Vygon S.A, a medical devices company launched easymoov6, an intuitive enteral feeding pump for management of chronic condition.
Moreover, small bore connectors are expected to have maximum impact on enteral feeding industry in upcoming years due to the increasing number of premature infants in critical care. For instance, according to the World Health Organization's February 2018 key facts, every year, an estimated 15 million infants are born preterm worldwide.
Furthermore, Increasing number of accidents and growing geriatric population is expected to boost growth of the market. For instance, according to National Informatics Center, India recorded a total of 467,044 road accidents in 2018. Moreover, according to United Nations Population Fund, geriatric population in Asia Pacific is expected to triple between 2010 and 2050 to reach 1.3 billion people by 2050.
Key features of the study:
“*” marked represents similar segmentation in other categories in the respective section.